Nationwide surveillance of circulatory collapse associated with levothyroxine administration in very-low-birthweight infants in Japan
Pediatrics International, 04/26/2012Kawai M et al.
Levothyroxine sodium (LT4) is widely used for infants, including very–low–birth–weight (VLBW) infants, and no major complications have been reported. However, these study revealed that more than a few cases of LCC were associated with the administration of LT4 in VLBW infants.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.